Nancy Lapid

(Reuters) – The following summarizes recent research on COVID-19. There is some research that needs to be further investigated to verify the results and has not been peer reviewed.

The Omicron breakthrough infection may save young hearts

One small study shows that Omicron, the variant of coronavirus, does not affect cardiovascular health in young adults who were vaccinated.

The earlier variants of Omicron have been known to cause damage to patients’ blood vessels and hearts. Researchers expected similar results when they compared the Omicron breakout infections in 23 Omicron-infected young adults diagnosed within six weeks with 13 COVID-19-vaccinated young people. Average age ranged from early to middle 20s for the participants in this study. According to Friday’s, cardiovascular markers included blood vessel function and responseness to stimuli as well as stiffness of the artery walls and heart rate variability. The researchers found no difference in these parameters between young healthy adults who had been vaccinated for COVID-19 and people who hadn’t.

Their findings that “not all variants could be detrimental to heart health in young, otherwise-healthy adults… are very encouraging.” There is evidence to suggest that the long-term effects on cardiovascular health can still occur. Long-term results in cardiovascular health will need to be determined through follow-up studies.

It is not necessary to delay mammography following COVID vaccination

Experts now advise that women should never delay routine mammograms following a COVID-19-mRNA vaccination.

Some women may experience swelling of the lymph nodes in the arms due to the vaccinations. This could lead to misinterpretation on mammograms as an indication that breast cancer is possible. After the first shot was administered, the Society for Breast Imaging suggested that women wait for at least four to six weeks before having screening mammograms. This is because the abnormalities were expected to resolve within that time. Research has shown that axillary lymphadenopathy, also known as axillary swelling after vaccinations can persist for longer periods than originally thought. Researchers reported that this swelling occurred in 111 patients who received an mRNACOVID vaccination. They experienced it for an average of 12-13 week before the condition resolved completely. The Society for Breast Imaging advises women not to delay mammograms for prolonged periods.

The group recommends that screening mammograms be performed six months after the initial exam to determine if there are any lymph node abnormalities. This is for women at average risk, asymptomatic breast cancer patients.

After fourth dose, mRNA vaccine responses are stronger than after third

The UK trial data shows that a fourth dose COVID-19-mRNA vaccine could increase antibody and other immune response levels to levels greater than the ones seen following the third dose.

After two doses each of AstraZeneca’s virus vector vaccine, or an initial dose with Pfizer/BioNTech shots, researchers recruited 166 adult subjects. The randomly selected recipients were given either another Pfizer/BionTech shot, or both. Moderna (NASDAQ)’s fourth dose of the mRNA boost. The average time since the last shot was seven years, with half of participants being older than 70. Researchers reported that antibodies against the coronavirus spike were twice as high two weeks later than levels four weeks earlier. This was regardless of the initial vaccination schedule. The T cell responses to the vaccine were noticeably higher 14 days after receiving the fourth dose than 28 days later. However, this was only for participants who had received three doses. Pfizer Followed by Moderna booster shots (NYSE:).

Researchers warned that the gains “will likely wane quickly, as was observed after third doses.” They said that participants with high immune response levels before the fourth shot had less boosting. This suggests that there could be a limit to the booster effect. People with higher antibody levels will not benefit from any additional doses.

You can click to see a list of vaccines currently in development.